Genetic polymorphism of merozoite surface protein 1 and antifolate-resistant genes in Plasmodium falciparum from Mali and Niger
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Since 2015, countries in the Sahel region have implemented large-scale seasonal malaria chemoprevention (SMC). However, the mass use of sulfadoxine-pyrimethamine (SP) plus amodiaquine impacts the genetic diversity of malaria parasites and their sensitivity to antimalarials. This study aimed to describe and compare the genetic diversity and SP resistance of Plasmodium falciparum strains in Mali and Niger. We collected 400 blood samples in Mali and Niger from children aged 3–59 months suspected of malaria. Of them, 201 tested positive (Niger, 111, 55.2%; Mali, 90, 44.8%). Polymorphism of merozoite surface protein 1 (msp1) genetic marker showed 201 allotypes. The frequency of the RO33 allotype was significantly higher in Niger (63.6%) than in Mali (39.3%). There was no significant difference in the frequency of the K1 and MAD20 allotypes between the 2 countries. The multiplicity of infection was 2 allotypes per patient in Mali and one allotype per patient in Niger. The prevalence of strains with the triple mutants Pfdhfr51I/Pfdhfr59R/Pfdhps436A/F/H and Pfdhfr51I/Pfdhfr59R/Pfdhps437G was 18.1% and 30.2%, respectively, and 7.7% carried the quadruple mutant Pfdhfr51I/Pfdhfr59R/Pfdhps436A/F/H/Pfdhps437G. Despite the significant genetic diversity of parasite populations, the level of SP resistance was comparable between Mali and Niger. The frequency of mutations conferring resistance to SP still allows its effective use in intermittent preventive treatment in pregnant women and in SMC.
Abstract
Since 2015, countries in the Sahel region have implemented large-scale seasonal malaria chemoprevention (SMC). However, the mass use of sulfadoxine-pyrimethamine (SP) plus amodiaquine impacts the genetic diversity of malaria parasites and their sensitivity to antimalarials. This study aimed to describe and compare the genetic diversity and SP resistance of Plasmodium falciparum strains in Mali and Niger. We collected 400 blood samples in Mali and Niger from children aged 3–59 months suspected of malaria. Of them, 201 tested positive (Niger, 111, 55.2%; Mali, 90, 44.8%). Polymorphism of merozoite surface protein 1 (msp1) genetic marker showed 201 allotypes. The frequency of the RO33 allotype was significantly higher in Niger (63.6%) than in Mali (39.3%). There was no significant difference in the frequency of the K1 and MAD20 allotypes between the 2 countries. The multiplicity of infection was 2 allotypes per patient in Mali and one allotype per patient in Niger. The prevalence of strains with the triple mutants Pfdhfr51I/Pfdhfr59R/Pfdhps436A/F/H and Pfdhfr51I/Pfdhfr59R/Pfdhps437G was 18.1% and 30.2%, respectively, and 7.7% carried the quadruple mutant Pfdhfr51I/Pfdhfr59R/Pfdhps436A/F/H/Pfdhps437G. Despite the significant genetic diversity of parasite populations, the level of SP resistance was comparable between Mali and Niger. The frequency of mutations conferring resistance to SP still allows its effective use in intermittent preventive treatment in pregnant women and in SMC.
참고문헌 (20)
- "Chimioprévention du paludisme saisonnier par administration de sulfadoxine-pyriméthamine et d’amodiaquine aux enfants: guide de terrain" (2013)[URL]
- Esu EB, "Intermittent preventive treatment for malaria in infants", Cochrane Database Syst Rev, 7(7), pp.CD011525~ (2021)[DOI]
- "Face au paludisme, le Niger généralise la chimioprévention pour les enfants"[URL]
- Noor AM, "Sub-national targeting of seasonal malaria chemoprevention in the sahelian countries of the nouakchott initiative", PLoS One, 10(8), pp.e0136919~ (2015)[DOI]
- "Intermittent preventive treatment of malaria in pregnancy using sulfadoxine-pyrimethamine (IPTp-SP): updated WHO policy recommendation"[URL]
- Marwa KJ, "Resistance to Cotrimoxazole and Other Antimicrobials among Isolates from HIV", AIDS and Non-HIV, AIDS Res Treat, pp.2015, 2015[DOI]
- Naidoo I, "Mapping ‘partially resistant’, ‘fully resistant’, and ‘super resistant’ malaria", Trends Parasitol, 29(10), pp.505~515 (2013)[DOI]
- Grais RF, "Molecular markers of resistance to amodiaquine plus sulfadoxine–pyrimethamine in an area with seasonal malaria chemoprevention in south central Niger", Malar J, 17(1), pp.98~ (2018)[DOI]
- Triglia T, "Cowman. Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum", Proc Natl Acad Sci U S A, 94(25), pp.13944~13949 (1997)[DOI]
- Lynch C, "Emergence of a dhfr Mutation conferring high-level drug resistance in Plasmodium falciparum populations from southwest Uganda", J Infect Dis, 197(11), pp.1598~1604 (2008)[DOI]
- "High Resolution Melting Analysis. HRM Technology"[URL]
- Yavo W, "Genetic polymorphism of msp1 and msp2 in Plasmodium falciparum isolates from Côte d’Ivoire versus Gabon", J Parasitol Res, 2016, pp.e3074803~ (2016)[DOI]
- Ibrahim A, "Etude du polymorphisme génétique des souches de Plasmodium falciparum au Niger", Revue CAMES SANTE, 5(1), pp.42~48 (2017)
- "Methods and Techniques for Clinical Trials on Antimalarial Drug Efficacy: genotyping to identify parasite populations: informal consultation organized by the Medicines for Malaria Venture and cosponsored by the World Health Organization" (2008)[URL]
- Ceesay SJ, "Malaria prevalence among young infants in different transmission settings, Africa", Emerg Infect Dis, 21(7), pp.1114~1121 (2015)[DOI]
- Diakité SAS, "A comprehensive analysis of drug resistance molecular markers and Plasmodium falciparum genetic diversity in two malaria endemic sites in Mali", Malar J, 18(1), pp.361~ (2019)[DOI]
- Daniels R, "Rapid, field-deployable method for genotyping and discovery of single-nucleotide polymorphisms associated with drug resistance in Plasmodium falciparum", Antimicrob Agents Chemother, 56(6), pp.2976~2986 (2012)[DOI]
- Dinzouna-Boutamba SD, "Assessment of genetic polymorphisms associated with malaria antifolate resistance among the population of Libreville, Gabon", Malar J, 22(2), pp.183~ (2023)[DOI]
- Wurtz N, "Prevalence of molecular markers of Plasmodium falciparum drug resistance in Dakar, Senegal", Malar J, 11(1), pp.197~ (2012)[DOI]
- Beshir KB, "Prevalence of Plasmodium falciparum haplotypes associated with resistance to sulfadoxine–pyrimethamine and amodiaquine before and after upscaling of seasonal malaria chemoprevention in seven African countries : a genomic surveillance study", Lancet Infect Dis, 23(3), pp.361~370 (2023)[DOI]